$2.47 Earnings Per Share Expected for HCA Healthcare Inc (HCA) This Quarter

Equities analysts predict that HCA Healthcare Inc (NYSE:HCA) will announce $2.47 earnings per share (EPS) for the current fiscal quarter, according to Zacks. Eleven analysts have issued estimates for HCA Healthcare’s earnings, with estimates ranging from $2.36 to $2.65. HCA Healthcare posted earnings of $2.29 per share during the same quarter last year, which indicates a positive year-over-year growth rate of 7.9%. The company is scheduled to announce its next earnings results on Wednesday, July 24th.

According to Zacks, analysts expect that HCA Healthcare will report full-year earnings of $10.40 per share for the current fiscal year, with EPS estimates ranging from $10.01 to $10.74. For the next year, analysts expect that the business will post earnings of $11.31 per share, with EPS estimates ranging from $10.49 to $12.59. Zacks Investment Research’s earnings per share calculations are an average based on a survey of sell-side analysts that follow HCA Healthcare.

HCA Healthcare (NYSE:HCA) last issued its earnings results on Tuesday, April 30th. The company reported $2.97 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $2.31 by $0.66. HCA Healthcare had a net margin of 7.71% and a negative return on equity of 112.65%. The company had revenue of $12.52 billion for the quarter, compared to the consensus estimate of $12.34 billion. During the same quarter in the previous year, the company earned $3.18 EPS. The firm’s revenue for the quarter was up 9.6% compared to the same quarter last year.

Several brokerages have recently commented on HCA. Zacks Investment Research upgraded shares of HCA Healthcare from a “hold” rating to a “buy” rating and set a $139.00 target price on the stock in a research note on Friday, May 3rd. Jefferies Financial Group set a $158.00 target price on shares of HCA Healthcare and gave the company a “buy” rating in a research note on Wednesday, April 17th. UBS Group boosted their target price on shares of HCA Healthcare from $164.00 to $172.00 and gave the company a “buy” rating in a research note on Wednesday, May 1st. Deutsche Bank upped their price target on shares of HCA Healthcare from $160.00 to $165.00 and gave the stock a “buy” rating in a research report on Wednesday, May 1st. Finally, ValuEngine downgraded shares of HCA Healthcare from a “buy” rating to a “hold” rating in a research report on Wednesday, March 6th. Two research analysts have rated the stock with a sell rating, three have given a hold rating and eighteen have given a buy rating to the company’s stock. The stock currently has an average rating of “Buy” and an average price target of $149.00.

Shares of NYSE:HCA opened at $126.01 on Tuesday. HCA Healthcare has a 52 week low of $101.30 and a 52 week high of $147.42. The firm has a market capitalization of $42.70 billion, a PE ratio of 11.98, a PEG ratio of 1.00 and a beta of 0.76.

The business also recently declared a quarterly dividend, which will be paid on Friday, June 28th. Investors of record on Monday, June 3rd will be given a dividend of $0.40 per share. The ex-dividend date is Friday, May 31st. This represents a $1.60 annualized dividend and a yield of 1.27%. HCA Healthcare’s dividend payout ratio (DPR) is 16.38%.

In other HCA Healthcare news, insider Jon M. Foster sold 44,281 shares of the business’s stock in a transaction dated Friday, May 10th. The stock was sold at an average price of $122.28, for a total transaction of $5,414,680.68. Following the completion of the sale, the insider now directly owns 96,052 shares of the company’s stock, valued at approximately $11,745,238.56. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. 2.70% of the stock is owned by corporate insiders.

A number of large investors have recently made changes to their positions in the business. Chicago Equity Partners LLC raised its holdings in HCA Healthcare by 4.6% during the 4th quarter. Chicago Equity Partners LLC now owns 1,841 shares of the company’s stock worth $229,000 after purchasing an additional 81 shares during the last quarter. Fifth Third Bancorp raised its holdings in HCA Healthcare by 4.2% during the 1st quarter. Fifth Third Bancorp now owns 2,101 shares of the company’s stock worth $274,000 after purchasing an additional 84 shares during the last quarter. Cornerstone Advisors Inc. raised its holdings in HCA Healthcare by 19.6% during the 1st quarter. Cornerstone Advisors Inc. now owns 587 shares of the company’s stock worth $77,000 after purchasing an additional 96 shares during the last quarter. Commonwealth Bank of Australia raised its holdings in HCA Healthcare by 3.6% during the 1st quarter. Commonwealth Bank of Australia now owns 2,883 shares of the company’s stock worth $374,000 after purchasing an additional 100 shares during the last quarter. Finally, Securian Asset Management Inc raised its holdings in HCA Healthcare by 0.4% during the 1st quarter. Securian Asset Management Inc now owns 27,942 shares of the company’s stock worth $3,643,000 after purchasing an additional 102 shares during the last quarter. 70.25% of the stock is owned by hedge funds and other institutional investors.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, provides health care services. The company operates general, acute care hospitals that offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy services.

Recommended Story: Differences Between Momentum Investing and Long Term Investing

Get a free copy of the Zacks research report on HCA Healthcare (HCA)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.